NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 9th March 2009 The Department of Health’s (DH) guidance on treatment for impotence (HSC1999/148) recommends in paragraph 5 that one treatment per week will be appropriate for most patients […]
Category Archives: Other therapeutics
NPC Archive Item: NICE guidelines on the management of breast cancer
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 5th March 2009 NICE has issued two clinical guidelines on management of breast cancer. Clinical Guideline 80 covers the tests and treatments that should be offered to patients with […]
NPC Archive Item: February Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 4th February 2009 The MHRA and CHM have published the February edition of Drug Safety Update. This issue gives […]
NPC Archive Item: EMEA recommends updating antiepileptic product information with warnings on suicidal risk
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30th January 2009 A small risk of suicidal thoughts and behaviour has recently been found to be associated with all antiepileptic medicines (about 2 additional patients per 1000). The […]
NPC Archive Item: Selenium, vitamin E or vitamin C do not prevent prostate cancer
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Two large, double-blind, placebo-controlled randomised trials fail to demonstrate a benefit of selenium, vitamin E or vitamin C in preventing prostate cancer. Action: Clinicians should not recommend the use […]
NPC Archive Item: December Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 11th December 2008 The MHRA and CHM have published the December edition of Drug Safety Update. This issue gives […]
NPC Archive Item: November Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 12th November 2008 The MHRA and CHM have published the November edition of Drug Safety Update. This issue highlights […]
NPC Archive Item: Early days for alemtuzumab▼ in early MS
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The CAMMS223 Trial Investigators. Alemtuzumab▼ vs. Interferon Beta-1a in Early Multiple Sclerosis. N Engl J Med 2008; 359:1786-801 Compared with interferon beta-1a, alemtuzumab▼ reduced the annualised risk of relapse and sustained […]
NPC Archive Item: FDA publishes a list of drugs being evaluated for potential safety issues
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. FDA. Potential signals of serious risks/new safety information Identified by the Adverse Event Reporting System (AERS). January – March 2008 The U.S. Food and Drug Administration (FDA) […]
NPC Archive Item: October Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 9th October 2008 The MHRA and CHM have published the October edition of Drug Safety Update. Included in this […]